CN Patent

CN101848895A — 血管新生抑制物质和抗肿瘤性铂络合物的组合使用

Assigned to Sanitary Material R&d Management Co ltd · Expires 2010-09-29 · 16y expired

What this patent protects

本发明的目的在于提供显示优异抗肿瘤效果的药物组合物及癌症治疗方法。4-(3-氯-4-(环丙基氨基羰基)氨基苯氧基)-7-甲氧基-6-氨甲酰喹啉及其类似化合物、或其药理学可接受的盐、或它们的溶剂合物通过与抗肿瘤性铂络合物组合使用，可显示出优异的抗肿瘤效果。

USPTO Abstract

本发明的目的在于提供显示优异抗肿瘤效果的药物组合物及癌症治疗方法。4-(3-氯-4-(环丙基氨基羰基)氨基苯氧基)-7-甲氧基-6-氨甲酰喹啉及其类似化合物、或其药理学可接受的盐、或它们的溶剂合物通过与抗肿瘤性铂络合物组合使用，可显示出优异的抗肿瘤效果。

Drugs covered by this patent

Patent Metadata

Patent number
CN101848895A
Jurisdiction
CN
Classification
—
Expires
2010-09-29
Drug substance claim
No
Drug product claim
No
Assignee
Sanitary Material R&d Management Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.